In about 90% of tumors, the genetic driver event involves a mutation in the glutamate receptor gene, GRM1, which seems unique to chondromyxoid fibroma and is rare to absent in other cartilaginous tumors. The gene discussed is GRM1; the disease is chondrogenic neoplasm.